Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 2000;8(5-6):244–247. doi: 10.1155/S1064744900000363

Value of Candida polymerase chain reaction and vaginal cytokine analysis for the differential diagnosis of women with recurrent vulvovaginitis.

S Weissenbacher 1, S S Witkin 1, V Tolbert 1, P Giraldo 1, I Linhares 1, A Haas 1, E R Weissenbacher 1, W J Ledger 1
PMCID: PMC1784693  PMID: 11220486

Abstract

OBJECTIVES: Recurrent vulvovaginitis remains difficult to diagnose accurately and to treat. The present investigation evaluated the utility of testing vaginal specimens from women with symptomatic recurrent vulvovaginitis for Candida species by polymerase chain reaction (PCR) and for cytokine responses. METHODS: Sixty-one consecutive symptomatic women with pruritus, erythema, and/or a thick white discharge and a history of recurrent vulvovaginitis and 31 asymptomatic women with no such history were studied. Vaginal swabs were tested for Candida species by PCR, for the antiinflammatory cytokine interleukin (IL)-10, and for the proinflammatory cytokine IL-12. RESULTS: C. albicans was detected in 19 (31.1%) of the patients as well as in three (9.7%) controls (P = 0.03). Both IL-10 (31.1% vs. 0%) and IL-12 (42.6% vs. 6.5%) were also more prevalent in the recurrent vulvovaginitis patients (P < 0.001). However, there was no relation between the presence or absence of Candida and either cytokine. Detection of IL-12 in 14 women indicated the stimulation of a vaginal cell-mediated immune response possibly from an infectious agent. The presence of only IL-10 in six patients indicated a suppression of vaginal cell-mediated immunity and was consistent with a possible allergic etiology. The absence of both IL-10 and IL-12 in other patients, similar to that found in healthy controls, suggested a noninfectious, nonallergic etiology of their symptoms. CONCLUSION: Many women with recurrent vulvovaginitis are not infected with Candida. Testing for Candida should be required in this population. Treatment with only anti-Candida medication will clearly be inadequate for the majority of women with this condition.

Full Text

The Full Text of this article is available as a PDF (641.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crampin A. C., Matthews R. C. Application of the polymerase chain reaction to the diagnosis of candidosis by amplification of an HSP 90 gene fragment. J Med Microbiol. 1993 Sep;39(3):233–238. doi: 10.1099/00222615-39-3-233. [DOI] [PubMed] [Google Scholar]
  2. Giraldo P., von Nowaskonski A., Gomes F. A., Linhares I., Neves N. A., Witkin S. S. Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis. Obstet Gynecol. 2000 Mar;95(3):413–416. doi: 10.1016/s0029-7844(99)00577-3. [DOI] [PubMed] [Google Scholar]
  3. Jeannin P., Delneste Y., Seveso M., Life P., Bonnefoy J. Y. IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J Immunol. 1996 May 1;156(9):3159–3165. [PubMed] [Google Scholar]
  4. Kalo-Klein A., Witkin S. S. Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infect Immun. 1990 Jan;58(1):260–262. doi: 10.1128/iai.58.1.260-262.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Morace G., Sanguinetti M., Posteraro B., Lo Cascio G., Fadda G. Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme analysis. J Clin Microbiol. 1997 Mar;35(3):667–672. doi: 10.1128/jcm.35.3.667-672.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D. H., Gubler U., Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med. 1997 Mar 3;185(5):825–831. doi: 10.1084/jem.185.5.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Szabo S. J., Dighe A. S., Gubler U., Murphy K. M. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med. 1997 Mar 3;185(5):817–824. doi: 10.1084/jem.185.5.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Witkin S. S., Hirsch J., Ledger W. J. A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am J Obstet Gynecol. 1986 Oct;155(4):790–795. doi: 10.1016/s0002-9378(86)80022-9. [DOI] [PubMed] [Google Scholar]
  9. Witkin S. S. Immunologic factors influencing susceptibility to recurrent candidal vaginitis. Clin Obstet Gynecol. 1991 Sep;34(3):662–668. [PubMed] [Google Scholar]
  10. Witkin S. S., Jeremias J., Ledger W. J. A localized vaginal allergic response in women with recurrent vaginitis. J Allergy Clin Immunol. 1988 Feb;81(2):412–416. doi: 10.1016/0091-6749(88)90909-8. [DOI] [PubMed] [Google Scholar]
  11. Witkin S. S., Jeremias J., Ledger W. J. Recurrent vaginitis as a result of sexual transmission of IgE antibodies. Am J Obstet Gynecol. 1988 Jul;159(1):32–36. doi: 10.1016/0002-9378(88)90489-9. [DOI] [PubMed] [Google Scholar]
  12. Witkin S. S., Jeremias J., Ledger W. J. Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis. J Med Vet Mycol. 1989;27(1):57–58. [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES